Use Coronary CTA First for Evaluating Patients with Stable Coronary Artery Disease
The American College of Cardiology recommends the United States join Europe in using this test first with this patient population.
Using coronary CT angiography to evaluate patients who have stable chest pain can improve their outcomes, as well as lower their costs, a group of experts have said.
In the September issue of the Journal of the American College of Cardiology, experts from the American College of Cardiology (ACC) published recommendations that point to a need to shift away from other tests toward greater coronary CTA use.
This guidance, based on the expert consensus from the ACC Summit on Technology Advances in Coronary Computed Tomography Angiography, reflects evidence showing that for patients with no known coronary artery disease, detection of the condition should pivot from identifying myocardial perfusion abnormality to pinpointing coronary atherosclerosis through CTA-first. Europe has already changed their guidelines based on these recommendations and evidence.
Related Content: CTA Improves Coronary Disease Risk Assessment
“In countries around the world, cardiac CT has been adopted as a first-line diagnostic test in patients with stable chest pain,” said Koen Nieman, M.D., Ph.D., Summit president, “and I have no doubt this strategy will be embraced in the U.S. as well if appropriate conditions can be established.”
Currently the U.S. ratio of SPECT myocardial perfusion imaging to coronary CTA testing is 58:1.
To move the industry toward coronary CTA-first, the ACC made these recommendations:
- Use coronary CTA as a first-line test for evaluating patients with stable chest pain and low-to-intermediate pre-test probability of obstructive CAD
- Explore options for “bundled payments” for cardiac testing
- Identify expert and financial support to increase the number of capable coronary CTA providers
- Develop strategies to improve provider and delivery team competency in performing coronary CTA
- Establish an ACC coronary CTA registry for evaluating chest pain that will include medical and economic variables for evaluating the total cost of care associated with coronary CTA
- Engage commercial payers in discussions on eliminating pre-approvals for coronary CTA and FFR CT for providers participating in the coronary CTA registry
- Improve education of cardiologists and primary care physicians on when to consider coronary CTA testing versus other techniques
The ACC did caution, however, that more wide-spread use of CTA does present challenges.
Although CT scanners are widely available, greater CTA implementation calls for more education and training of medical professionals (both radiologists and cardiologists) to ensure they capture images of high diagnostic quality. In addition, providers need higher reimbursement for the service, and improvements must be made with insurance pre-authorizations.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
